Table 2. Relative survival for Australian children diagnosed with cancer by diagnostic group and stage, 1997–2006a.
|
Relative survival (95% confidence intervals)
|
||||
|---|---|---|---|---|
| Diagnostic group and stage | N b | 1 year | 5 year | 20 year |
| II. Lymphomas | ||||
| Stage I | 259 | 98.4 (93.8–99.6) | 96.3 (91.3–98.5) | 96.5 (91.2–99.1) |
| Stage II | 259 | 99.2 (94.6–99.9) | 96.9 (91.9–98.9) | 94.5 (88.4–97.7) |
| Stage III | 321 | 90.6 (85.1–94.1) | 84.3 (77.9–89.0) | 80.1 (71.6–86.3) |
| Stage IV | 138 | 92.8 (83.5–96.9) | 86.1 (74.8–92.6) | 85.0 (73.1–92.1) |
| Unknown | 243 | 87.1 (79.7–91.9) | 85.2 (77.4–90.5) | 85.0 (77.0–90.6) |
| IV. Neuroblastoma | ||||
| Stage I | 104 | 98.7 (89.7–100.0) | 95.6 (86.3–98.8) | 96.0 (86.6–99.2) |
| Stage II | 88 | 100.0 NA | 90.9 (77.1–96.7) | 91.3 (77.4–97.1) |
| Stage III | 102 | 87.7 (74.4–94.4) | 74.4 (59.1–84.7) | 74.7 (59.3–85.1) |
| Stage IV | 297 | 81.7 (75.5–86.5) | 49.3 (42.0–56.2) | 41.8 (33.8–49.7) |
| Unknown | 59 | 91.1 (68.6–97.8) | 91.2 (68.7–97.9) | 86.9 (63.3–96.2) |
| VI. Renal tumours | ||||
| Stage I | 190 | 98.7 (90.3–99.9) | 94.8 (86.4–98.1) | 90.6 (80.3–95.8) |
| Stage II | 135 | 100.0 NA | 93.2 (84.1–97.2) | 93.6 (84.5–97.7) |
| Stage III | 165 | 97.4 (89.8–99.4) | 92.3 (83.5–96.5) | 91.3 (82.0–96.1) |
| Stage IV | 122 | 91.2 (81.3–96.0) | 75.1 (62.9–83.7) | 73.7 (61.3–82.8) |
| Unknown | 71 | 84.8 (69.2–92.9) | 84.9 (69.2–93.0) | 85.4 (69.6–93.6) |
| IXA. Rhabdomyosarcomas | ||||
| Stages I/II | 115 | 97.0 (88.2–99.3) | 86.4 (75.3–92.7) | 81.3 (66.5–90.2) |
| Stages III/IV | 123 | 89.2 (77.6–95.0) | 55.9 (42.5–67.4) | 47.1 (34.8–58.6) |
| Unknown | 105 | 91.2 (78.2–96.6) | 68.9 (46.1–83.6) | 66.3 (44.5–81.3) |
Abbreviation: NA=not applicable.
a
Includes all children who were diagnosed between January 1st 1983 and December 31st 2006, and were ‘at risk’ at some point between 1997 and 2006 (inclusive).
b
N represents the total number ‘at risk’ between 1997 and 2006 (inclusive).